SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-13-002961
Filing Date
2013-05-31
Accepted
2013-05-31 06:45:20
Documents
3
Period of Report
2013-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 SUCAMPO PHARMACEUTICALS, INC. 8-K a50643488.htm 8-K 22048
2 EXHIBIT 99.1 a50643488ex99_1.htm EX-99.1 84766
3 LOGO logo.jpg GRAPHIC 6652
  Complete submission text file 0001157523-13-002961.txt   117194
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33609 | Film No.: 13883465
SIC: 2834 Pharmaceutical Preparations